1. Home
  2. MPB vs TBPH Comparison

MPB vs TBPH Comparison

Compare MPB & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MPB
  • TBPH
  • Stock Information
  • Founded
  • MPB 1868
  • TBPH 2013
  • Country
  • MPB United States
  • TBPH United States
  • Employees
  • MPB N/A
  • TBPH N/A
  • Industry
  • MPB Major Banks
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • MPB Finance
  • TBPH Health Care
  • Exchange
  • MPB Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • MPB 467.7M
  • TBPH 464.5M
  • IPO Year
  • MPB N/A
  • TBPH N/A
  • Fundamental
  • Price
  • MPB $28.20
  • TBPH $8.98
  • Analyst Decision
  • MPB Buy
  • TBPH Buy
  • Analyst Count
  • MPB 2
  • TBPH 3
  • Target Price
  • MPB $36.00
  • TBPH $11.33
  • AVG Volume (30 Days)
  • MPB 137.0K
  • TBPH 264.4K
  • Earning Date
  • MPB 04-23-2025
  • TBPH 05-08-2025
  • Dividend Yield
  • MPB 2.84%
  • TBPH N/A
  • EPS Growth
  • MPB 23.94
  • TBPH N/A
  • EPS
  • MPB 2.88
  • TBPH N/A
  • Revenue
  • MPB $181,865,000.00
  • TBPH $65,266,000.00
  • Revenue This Year
  • MPB $19.07
  • TBPH $51.09
  • Revenue Next Year
  • MPB $11.53
  • TBPH N/A
  • P/E Ratio
  • MPB $9.80
  • TBPH N/A
  • Revenue Growth
  • MPB 8.94
  • TBPH 6.11
  • 52 Week Low
  • MPB $19.75
  • TBPH $7.44
  • 52 Week High
  • MPB $33.87
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • MPB 56.40
  • TBPH 41.09
  • Support Level
  • MPB $26.16
  • TBPH $9.90
  • Resistance Level
  • MPB $29.57
  • TBPH $10.55
  • Average True Range (ATR)
  • MPB 1.16
  • TBPH 0.36
  • MACD
  • MPB 0.09
  • TBPH -0.02
  • Stochastic Oscillator
  • MPB 63.93
  • TBPH 15.82

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: